Preterm Birth Prevention and Management Market
Market Insights on Preterm Birth Prevention and Management covering sales outlook, demand forecast & up-to-date key trends
Preterm Birth Prevention and Management Market by Therapy Type (Progesterone Therapy, Corticosteroid Therapy, Tocolytics Therapy, Antihypertensive Therapy, Magnesium Sulfate Therapy, Heparin Prophylaxis Therapy, Low-Dose Aspirin Therapy, Antibiotics Therapy) & Region for 2022-2029
Preterm Birth Prevention and Management Market Outlook – 2022-2029
[302 Pages Report] The global Preterm Birth Prevention and Management Market is estimated to be worth around US$ 1.41 Bn in 2022. With increasing adoption of preterm birth prevention and management therapeutics across both developed and developing regions, the overall market is anticipated to grow at 10.1% CAGR between 2022 and 2029, totaling a valuation of US$ 2 .78 Bn by 2029.
|
Attribute |
Details |
|
Preterm Birth Prevention and Management Market Estimated Size in 2022 |
US$ 1.41 Bn |
|
Preterm Birth Prevention and Management Market Projected Size in 2029 |
US$ 2.78 Bn |
|
Preterm Birth Prevention and Management Market Historical CAGR (2014-2021) |
7.9% |
|
Preterm Birth Prevention and Management Market Value-Based CAGR (2022-2029) |
10.1% |
Preterm birth has become a major healthcare problem and a significant contributor to perinatal mortality and disability worldwide. In order to address this issue, various approaches are being employed by healthcare workers. This is in turn providing impetus to the preterm birth prevention and management market and the trend is likely to continue in the future. Currently preterm birth prevention and management represents 12.4% of the global prenatal care market.
Regionally, North America and South Asia remain the two most attractive markets for preterm birth prevention and management therapeutic, owing to the rising prevalence of preterm birth, presence of leading market players, new drug development and approvals and increasing government support.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
9.67% |
|
H1, 2022 Projected |
10.08% |
|
H1, 2022 Outlook |
8.98% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 110 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 69 ↓ |
H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 110 BPS. In H1-2022, the market growth rate of preterm birth prevention and management is expected to fall by 69 basis point share (BPS), as per FMI analysis.
The key developments in the market include the specified WHO guidelines in the management of preterm birth and management of overall maternal health. The market is highly influenced by biologic manufacturing impositions, regulatory framework, and licensing of therapeutic agents.
The market decline observed through the drop in the BPS values is addressed by the advent of the COVID-19 pandemic and the resultant halt in the production capacities as well as supply chain disruptions. This notable change reduced the proliferation of preterm birth prevention therapeutics.
Consequently, the development of several government initiatives to improve maternal and child health will support the market growth, and will likely result in the advancement in growth of the overall preterm birth prevention and management market.
2014-2021 Preterm Birth Prevention and Management Market Outlook Compared to 2021-2029 Forecast
As per FMI, the global preterm birth prevention and management market is set to register a steady CAGR of 10.1% between 2022 and 2029 in comparison to 7.9% CAGR registered from 2014 to 2021.
Rising need for preventing preterm births, growing health awareness among people and increasing emphasis on targeted therapies are some of the factors driving the global preterm birth prevention and management market.
The increasing prevalence of preterm births at an alarming rate has become one of the major concerns for healthcare workers and governing bodies worldwide. It not only puts life of both baby and mother in danger but also incurs heavy financial losses.
According to the World Health Organization (WHO), an estimated 15 million babies are born preterm every year and around 1 million children die each year due to complications of preterm birth. This rise in preterm births worldwide is providing the major thrust to the growth of preterm birth prevention and management market and the trend is likely to continue in the future.
Consequently, increasing adoption of preterm diagnostic tests for better assessment is positively impacting the growth of preterm birth prevention and management market.
Leading market players are vigorously spending on research activities for developing novel treatment approaches. New combination therapies are being studied for the proper management of preterm birth and post preterm birth complications worldwide.
For instance, in 2021, researchers at the University of Texas Medical Branch (UTMB) developed a new treatment approach that could reduce the incidence of preterm birth, while treating the fetus as the patient.
Besides this, they are aiming at penetrating the lucrative market of developing regions to increase their sales.
Spurred by aforementioned factors, the preterm birth prevention and management market is set to expand 1.96X through 2029.
What are the Factors Driving Preterm Birth Prevention and Management Market?
“Growing Concerns Regarding High Mortality Rate of Preterm Birth Triggering Growth”
Preterm birth is defined as the delivery of a fetus before 37 weeks of pregnancy. Early child birth can lead to various complications including long term disability and death of the child. It is one of the leading causes of neonatal death. According to the World Health Organization (WHO), Preterm birth complications were the leading cause of death among children under 5 years of age in 2015.
Rising concerns regarding the long-term disability and mortality rate of preterm birth are impelling the adoption of various treatment approaches like progesterone and corticosteroid therapies. Growing popularity of these treatment approaches among people will continue to spur the growth of preterm birth prevention and management market over the assessment period.
“Increasing Initiatives Taken by Government and Private Organizations Pushing Sales”
Amid rising mortality rate associated with preterm births, improving prenatal health has become a top priority for both protecting the child as well as the mother. Various initiatives have been adopted by government and private organizations from time to time to develop proper prenatal care infrastructure. This has created huge space for the leading market players.
Moreover, various investments are being allocated to healthcare institutions for reducing preterm birth and improving prenatal care across the world.
For instance, in 2021, the National Consumer League (NCL) along with patient advocacy organizations launched Preterm Birth Prevention Alliance (PBPA) to reduce recurrent preterm birth cases.
Similarly in September 2021, the U.S. Department of Health and Human Services (HHS) awarded nearly US$ 350 million in awards to states across the nation to support safe pregnancies and healthy babies
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
Why is the Preterm Birth Prevention and Management Market Flourishing in India?
“Rising Incidence of Preterm Birth Augmenting Market Growth”
During the last few years India has emerged as a highly lucrative market for preterm birth prevention and management therapeutics across South Asia. The market in the country is driven by rapidly increasing population, rising governmental support, increasing prevalence of preterm birth and growing health awareness among people.
Rising cases of preterm births and high infant mortality rate are creating high demand for preterm birth prevention and management therapeutics across the country. According to the World Health organization (WHO), India remains the biggest contributor to the global burden of preterm births, accounting for over 3,519 100 cases.
Various initiatives and campaigns are being launched by both government and private organizations to tackle the rising burden of preterm births. This will further support the growth of term birth prevention and management market in the country over the assessment period.
What is the Market Outlook for China?
“Increase in Spontaneous Preterm Births Pushing Sales in China”
As per FMI, the China preterm birth prevention and management market is anticipated to grow at a stupendous CAGR over the forecast period. Increasing cases of spontaneous preterm births, easy availability of multiple therapeutics at affordable rates and favorable government regulations are some of the major factors driving the preterm birth prevention and management market in China.
During the last few years, China has witnessed a sharp increase in the cases of preterm births. The country has become the second biggest contributor to the global burden of preterm births with over 1 172 300 cases as per WHO. This rise in preterm birth cases has put preterm birth prevention and management market into the spotlight.
Moreover, the presence of favorable regulations and increasing investments by government on developing the country’s neonatal care infrastructure is positively impacting market growth and the trend is likely to continue in the future.
Why is the U.S. Considered a Leading Market for Preterm Birth Prevention and management?
“Presence of Leading Market Players and Favorable Reimbursement Policies Triggering Growth in U.S.”
The U.S. has become one of the most lucrative markets for preterm birth prevention and management due to heavy presence of leading market players, highly established healthcare sector, rising diagnostic rates, availability of favorable reimbursement policies and growing awareness among people regarding pregnancy and infant loss.
Changing lifestyle along with increasing adoption of assistant reproductive technologies in the country has resulted in more multiple pregnancies with high complications. This has pushed the number of preterm births to new heights.
However, with continuous advances in prenatal care and rising government support, the country is gradually becoming successful in countering this rising issue of preterm birth. Huge amounts are being constantly spent on diagnostic tests and preterm birth management treatments.
Moreover, the country is home to some of the leading pharmaceutical giants who are increasingly developing innovative drugs for addressing the preterm birth issue.
Category-wise Insights
Which is the Most Commonly Used Therapy Type for Preterm Birth Prevention and Management?
“Progesterone Therapy Remains Highly Sought After for Preventing Preterm Birth”
As per FMI, progesterone therapy will continue to remain the most preferred treatment for preventing preterm births owing to its fast action and better efficacy. It is highly recommended by healthcare professionals as it doesn’t require surgery or anesthesia.
Progesterone helps to prevent preterm birth in patients with short cervix, prior spontaneous PTB and several other complications.
Increasing adoption of progesterone therapy for preterm birth prevention and management is anticipated to accelerate the growth of the market at a prolific pace during the forecast period.
Which is the Most Preferred Route of Administration for Preterm Birth Prevention and Management Therapeutics?
“Faster and Higher Bioavailability of Parenteral Route of Administration Making it a Preferred Choice”
Based on route of administration, the global preterm birth prevention and management market is categorized into oral, parenteral and vaginal. Among these, parenteral segment is anticipated to continue its dominance in the global preterm birth prevention and management market, accounting for a major share of 79.3 in 2022.
Healthcare workers mostly administer preterm birth prevention and management therapeutics such as progesterone and corticosteroid through parenteral route due to its various advantages. The parenteral route of administration offers improved bioavailability, reliable dosing and avoidance of the first pass metabolism.
Which Distribution Channel Will Witness Maximum Sales of Preterm Birth Prevention and Management Drugs?
“Hospital Pharmacies Remain the Most Preferred Distribution Channel for Preterm Birth Prevention and Management Therapeutics”
In terms of distribution channel, preterm birth prevention and management market has been segmented into hospital pharmacies, retail pharmacies, drug stores and mail order pharmacies. Among these, the hospital pharmacies segment accounts for the largest revenue share and is projected to continue its dominance during the forecast period.
Most of the patients prefer to opt for treatment at government hospitals in order to minimize the overall costs. As a result, hospital pharmacies witness more demand for preterm birth prevention and management therapeutics and the trend is likely to continue in the future.
Moreover, shareholders continue to allocate their capitals to hospital pharmacies for distribution of preterm birth prevention and management drugs.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Competitive Landscape
Leading companies operating in the global preterm birth prevention and management market have adopted various organic and inorganic strategies such as mergers, partnerships, new product launches and approvals, collaborations and acquisitions for expanding their global presence. For instance,
- In August 2021, the U.S. Food and Drug Administration granted a public hearing to discuss Makena, the only FDA approved treatment for reducing preterm birth in indicated patients, as per Covis Group.
- In 2020, Covis Group acquired AMAG Pharmaceuticals to become a global market leader of therapeutic solutions for various life-threatening conditions and chronic illness.
- In July 2019, Novartis AG announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended its approval of Lucentis for the treatment of preterm infants with retinopathy of prematurity.
Scope of the Report
|
Attribute |
Details |
|
Historical Data Available for |
2014-2021 |
|
Forecast Period |
2022-2029 |
|
Market Analysis |
Units for Volume and US$ Mn for Value |
|
Key Regions Covered |
North America, Europe, Latin America, South Asia, East Asia, Oceania and Middle East and Africa |
|
Key Countries Covered |
US, Canada, Mexico, Brazil, Germany, U.K., France, Italy, Spain, Russia, Poland, China, Japan, South Korea, India, ASEAN, Turkey and South Africa |
|
Key Segments Covered |
Therapy Type, Route of Administration, Patient Type, Distribution Channel, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Preterm Birth Prevention and Management Market by Category
By Therapy Type:
- Progesterone Therapy
- Corticosteroid Therapy
- Tocolytics Therapy
- Antihypertensive Therapy
- Magnesium Sulfate Therapy
- Heparin Prophylaxis Therapy
- Low-Dose Aspirin Therapy
- Antibiotics Therapy
By Route of Administration:
- Oral
- Parenteral
- Vaginal
By Patient Type:
- Prior Spontaneous PTB
- Preeclampsia
- Short Cervix
- Chronic Hypertension
- Insulin-dependent
- Twins
- Antiphospholipid Antibody Syndrome
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Mail Order Pharmacies
By Region:
- North America
- Europe
- Latin America
- South Asia
- East Asia
- Oceania
- Middle East and Africa
Frequently Asked Questions
What is the current preterm birth prevention and management market valuation?
The preterm birth prevention and management market is estimated to be worth around US$ 1.41Bn in 2022.
What is the demand outlook for preterm birth prevention and management market?
As per FMI, the preterm birth prevention and management market is forecast to register a CAGR of 10.1% between 2022 and 2029
At what rate did the preterm birth prevention and management market grow between 2014 and 2021?
The preterm birth prevention and management market grew at a CAGR of 7.9% between 2014 and 2021.
What are the key trends shaping the preterm birth prevention and management market?
Introduction of new therapeutics, rising government support and surging cases of preterm births are some of the key trends shaping the growth of the market.
Who are the leading players in preterm birth prevention and management market?
Aquatic Remedies Pvt. Ltd., Teva Pharmaceuticals USA, Inc., Anglo French Drugs & Industries Limited, Biophar Lifesciences Pvt. Ltd., Jasco Labs (P) Ltd., BSA Pharma Inc., Novartis AG, Sanofi S.A, AMAG Pharmaceuticals, Pfizer Inc., and Mylan are some of the leading players operating in the preterm birth prevention and management market.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Market Background 4.1. Macro-Economic Factors 4.1.1. Global GDP Growth Outlook 4.1.2. Global Healthcare Expenditure Outlook 4.2. Forecast Factors - Relevance & Impact 4.2.1. Incidences of Preterm Birth 4.2.2. Treatment Cost 4.2.3. Availability of Reimbursement 4.2.4. Awareness Regarding Preterm Birth Prevention 4.2.5. Expected Drug Launches 4.3. Value Chain Analysis 4.4. Market Dynamics 4.4.1. Drivers 4.4.2. Restraints 4.5. Opportunity Analysis 5. Key Success Factors 5.1. Epidemiology of Preterm Birth for Top Countries 5.2. Treatment Regime by Patient Type 5.3. Research and Development Strategies by Key Vendors 5.4. Regulatory Scenario 5.5. Exhaustive List of FDA and EMA approved Drugs 5.6. Pipeline Assessment 5.7. Reimbursement Landscape for Top Countries 5.8. Patent Scenario 5.9. Emerging drug delivery platform for PTB prevention & management 5.10. Key Marketed Drug - Historic Sales Analysis and Forecast 5.11. License Deal Summary for Key Marketed Drugs 5.12. Medical Need Assessment / Gap Analysis 6. Global Preterm Birth Prevention and Management Market Pricing Analysis 6.1. Regional Pricing Analysis By Therapy Type 6.2. Global Average Pricing Analysis Benchmark 7. Global Preterm Birth Prevention and Management Market Value (US$ Mn) Analysis 2014-2021 and Forecast, 2022-2029 7.1. Historical Market Value (US$ Mn) Analysis, 2014-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029, by Therapy Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Therapy Type, 2014-2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapy Type, 2022-2029 8.3.1. Progesterone Therapy 8.3.2. Corticosteroid Therapy 8.3.3. Tocolytics Therapy 8.3.4. Antihypertensive Therapy 8.3.5. Magnesium Sulfate Therapy 8.3.6. Heparin Prophylaxis Therapy 8.3.7. Low-Dose Aspirin Therapy 8.3.8. Antibiotics Therapy 8.4. Market Attractiveness Analysis By Therapy Type 9. Global Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029, by Route of Administration 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014-2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022-2029 9.3.1. Oral 9.3.2. Parenteral 9.3.3. Vaginal 9.4. Market Attractiveness Analysis By Route of Administration 10. Global Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029, by Patient Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014-2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Patient Type, 2022-2029 10.3.1. Prior Spontaneous PTB 10.3.2. Preeclampsia 10.3.3. Short Cervix 10.3.4. Chronic Hypertension 10.3.5. Insulin-dependent 10.3.6. Twins 10.3.7. Antiphospholipid Antibody Syndrome 10.3.8. Others 10.4. Market Attractiveness Analysis By Patient Type 11. Global Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029, By Distribution Channel 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2029 11.3.1. Hospital Pharmacies 11.3.2. Retail Pharmacies 11.3.3. Drug Stores 11.3.4. Mail Order Pharmacies 11.4. Market Attractiveness Analysis By Distribution Channel 12. Global Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2021 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2029 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. South Asia 12.3.5. East Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 - 2028 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Therapy Type 13.3.3. By Route of Administration 13.3.4. By Patient Type 13.3.5. By Distribution Channel 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 - 2028 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Therapy Type 14.3.3. By Route of Administration 14.3.4. By Patient Type 14.3.5. By Distribution Channel 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 - 2028 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. BENELUX 15.3.1.7. Russia 15.3.1.8. Poland 15.3.1.9. Rest of Europe 15.3.2. By Therapy Type 15.3.3. By Route of Administration 15.3.4. By Patient Type 15.3.5. By Distribution Channel 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 - 2028 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Singapore 16.3.1.4. Indonesia 16.3.1.5. Malaysia 16.3.1.6. Rest of South Asia 16.3.2. By Therapy Type 16.3.3. By Route of Administration 16.3.4. By Patient Type 16.3.5. By Distribution Channel 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 - 2028 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Therapy Type 17.3.3. By Route of Administration 17.3.4. By Patient Type 17.3.5. By Distribution Channel 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 - 2028 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Therapy Type 18.3.3. By Route of Administration 18.3.4. By Patient Type 18.3.5. By Distribution Channel 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021 - 2028 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Turkey 19.3.1.3. South Africa 19.3.1.4. Rest of Middle East and Africa 19.3.2. By Therapy Type 19.3.3. By Route of Administration 19.3.4. By Patient Type 19.3.5. By Distribution Channel 19.4. Market Attractiveness Analysis 19.5. Key Market Participants - Intensity Mapping 19.6. Drivers and Restraints - Impact Analysis 20. Emerging Countries Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. China Preterm Birth Prevention and Management Market Analysis 20.2.1. Introduction 20.2.2. Market Value Proportion Analysis by Market Taxonomy 20.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 20.2.3.1. By Therapy Type 20.2.3.2. By Route of Administration 20.2.3.3. By Patient Type 20.2.3.4. By Distribution Channel 20.3. India Preterm Birth Prevention and Management Market Analysis 20.3.1. Introduction 20.3.2. Market Value Proportion Analysis by Market Taxonomy 20.3.3. Market and Value (US$ Mn) Analysis and Forecast by Market Taxonomy 20.3.3.1. By Therapy Type 20.3.3.2. By Route of Administration 20.3.3.3. By Patient Type 20.3.3.4. By Distribution Channel 20.4. Brazil Preterm Birth Prevention and Management Market Analysis 20.4.1. Introduction 20.4.2. Market Value Proportion Analysis by Market Taxonomy 20.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 20.4.3.1. By Therapy Type 20.4.3.2. By Route of Administration 20.4.3.3. By Patient Type 20.4.3.4. By Distribution Channel 21. U.S. Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029 21.1. Introduction 21.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021 21.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029 21.3.1. By Therapy Type 21.3.2. By Route of Administration 21.3.3. By Patient Type 21.3.4. By Distribution Channel 21.4. Market Attractiveness Analysis 22. Canada Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029 22.1. Introduction 22.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021 22.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029 22.3.1. By Therapy Type 22.3.2. By Route of Administration 22.3.3. By Patient Type 22.3.4. By Distribution Channel 22.4. Market Attractiveness Analysis 23. Japan Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029 23.1. Introduction 23.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021 23.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029 23.3.1. By Therapy Type 23.3.2. By Route of Administration 23.3.3. By Patient Type 23.3.4. By Distribution Channel 23.4. Market Attractiveness Analysis 24. South Korea Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029 24.1. Introduction 24.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021 24.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029 24.3.1. By Therapy Type 24.3.2. By Route of Administration 24.3.3. By Patient Type 24.3.4. By Distribution Channel 24.4. Market Attractiveness Analysis 25. Australia Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029 25.1. Introduction 25.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021 25.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029 25.3.1. By Therapy Type 25.3.2. By Route of Administration 25.3.3. By Patient Type 25.3.4. By Distribution Channel 25.4. Market Attractiveness Analysis 26. New Zealand Preterm Birth Prevention and Management Market Analysis 2014-2021 and Forecast 2022-2029 26.1. Introduction 26.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021 26.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2029 26.3.1. By Therapy Type 26.3.2. By Route of Administration 26.3.3. By Patient Type 26.3.4. By Distribution Channel 26.4. Market Attractiveness Analysis 27. Market Structure Analysis 27.1. Market Analysis by Tier of Companies 27.2. Market Concentration 27.3. Market Share Analysis of Top Players 27.4. Market Presence Analysis 27.4.1. By Regional footprint of Players 27.4.2. Product foot print by Players 28. Competition Analysis 28.1. Competition Dashboard 28.2. Competition Benchmarking 28.3. Competition Deep Dive 28.3.1. Teva Pharmaceutical Industries Ltd. 28.3.1.1. Overview 28.3.1.2. Product Portfolio 28.3.1.3. Profitability by Market Segments (Product/Channel/Region) 28.3.1.4. Sales Footprint 28.3.1.5. Strategy Overview 28.3.1.5.1. Marketing Strategy 28.3.1.5.2. Product Strategy 28.3.1.5.3. Channel Strategy 28.3.2. Allergan, Inc. 28.3.2.1. Overview 28.3.2.2. Product Portfolio 28.3.2.3. Profitability by Market Segments (Product/Channel/Region) 28.3.2.4. Sales Footprint 28.3.2.5. Strategy Overview 28.3.2.5.1. Marketing Strategy 28.3.2.5.2. Product Strategy 28.3.2.5.3. Channel Strategy 28.3.3. Ferring Pharmaceuticals 28.3.3.1. Overview 28.3.3.2. Product Portfolio 28.3.3.3. Profitability by Market Segments (Product/Channel/Region) 28.3.3.4. Sales Footprint 28.3.3.5. Strategy Overview 28.3.3.5.1. Marketing Strategy 28.3.3.5.2. Product Strategy 28.3.3.5.3. Channel Strategy 28.3.4. AbbVie Inc. 28.3.4.1. Overview 28.3.4.2. Product Portfolio 28.3.4.3. Profitability by Market Segments (Product/Channel/Region) 28.3.4.4. Sales Footprint 28.3.4.5. Strategy Overview 28.3.4.5.1. Marketing Strategy 28.3.4.5.2. Product Strategy 28.3.4.5.3. Channel Strategy 28.3.5. Aurobindo Pharma Limited 28.3.5.1. Overview 28.3.5.2. Product Portfolio 28.3.5.3. Profitability by Market Segments (Product/Channel/Region) 28.3.5.4. Sales Footprint 28.3.5.5. Strategy Overview 28.3.5.5.1. Marketing Strategy 28.3.5.5.2. Product Strategy 28.3.5.5.3. Channel Strategy 28.3.6. Bayer AG 28.3.6.1. Overview 28.3.6.2. Product Portfolio 28.3.6.3. Profitability by Market Segments (Product/Channel/Region) 28.3.6.4. Sales Footprint 28.3.6.5. Strategy Overview 28.3.6.5.1. Marketing Strategy 28.3.6.5.2. Product Strategy 28.3.6.5.3. Channel Strategy 28.3.7. Mylan N.V. 28.3.7.1. Overview 28.3.7.2. Product Portfolio 28.3.7.3. Profitability by Market Segments (Product/Channel/Region) 28.3.7.4. Sales Footprint 28.3.7.5. Strategy Overview 28.3.7.5.1. Marketing Strategy 28.3.7.5.2. Product Strategy 28.3.7.5.3. Channel Strategy 28.3.8. Pfizer Inc. 28.3.8.1. Overview 28.3.8.2. Product Portfolio 28.3.8.3. Profitability by Market Segments (Product/Channel/Region) 28.3.8.4. Sales Footprint 28.3.8.5. Strategy Overview 28.3.8.5.1. Marketing Strategy 28.3.8.5.2. Product Strategy 28.3.8.5.3. Channel Strategy 28.3.9. Merck & Co., Inc 28.3.9.1. Overview 28.3.9.2. Product Portfolio 28.3.9.3. Profitability by Market Segments (Product/Channel/Region) 28.3.9.4. Sales Footprint 28.3.9.5. Strategy Overview 28.3.9.5.1. Marketing Strategy 28.3.9.5.2. Product Strategy 28.3.9.5.3. Channel Strategy 28.3.10. AMAG Pharmaceuticals 28.3.10.1. Overview 28.3.10.2. Product Portfolio 28.3.10.3. Profitability by Market Segments (Product/Channel/Region) 28.3.10.4. Sales Footprint 28.3.10.5. Strategy Overview 28.3.10.5.1. Marketing Strategy 28.3.10.5.2. Product Strategy 28.3.10.5.3. Channel Strategy 28.3.11. Bausch Health Companies Inc. 28.3.11.1. Overview 28.3.11.2. Product Portfolio 28.3.11.3. Profitability by Market Segments (Product/Channel/Region) 28.3.11.4. Sales Footprint 28.3.11.5. Strategy Overview 28.3.11.5.1. Marketing Strategy 28.3.11.5.2. Product Strategy 28.3.11.5.3. Channel Strategy 28.3.12. Novartis International AG 28.3.12.1. Overview 28.3.12.2. Product Portfolio 28.3.12.3. Profitability by Market Segments (Product/Channel/Region) 28.3.12.4. Sales Footprint 28.3.12.5. Strategy Overview 28.3.12.5.1. Marketing Strategy 28.3.12.5.2. Product Strategy 28.3.12.5.3. Channel Strategy 28.3.13. Sun Pharmaceutical Industries Ltd. 28.3.13.1. Overview 28.3.13.2. Product Portfolio 28.3.13.3. Profitability by Market Segments (Product/Channel/Region) 28.3.13.4. Sales Footprint 28.3.13.5. Strategy Overview 28.3.13.5.1. Marketing Strategy 28.3.13.5.2. Product Strategy 28.3.13.5.3. Channel Strategy 28.3.14. Sanofi S.A. 28.3.14.1. Overview 28.3.14.2. Product Portfolio 28.3.14.3. Profitability by Market Segments (Product/Channel/Region) 28.3.14.4. Sales Footprint 28.3.14.5. Strategy Overview 28.3.14.5.1. Marketing Strategy 28.3.14.5.2. Product Strategy 28.3.14.5.3. Channel Strategy 29. Assumptions and Acronyms Used 30. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Expenditure on Health (% of GDP) by Country, 2016 - 2021 Table 02: Expenditure on Health (% of GDP) by Country, 2016 - 2021 Table 03: Pricing Analysis by Therapy Type, 2021 Table 04: Global Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 05: Global Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 06: Global Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 07: Global Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 08: Global Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Region Table 09: North America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Country Table 10: North America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 11: North America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 12: North America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 13: North America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 14: Latin America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Country Table 15: Latin America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 16: Latin America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 17: Latin America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 18: Latin America Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 19: Europe Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Country Table 20: Europe Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 21: Europe Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 22: Europe Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 23: Europe Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 24: South Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Country Table 25: South Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 26: South Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 27: South Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 28: South Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 29: East Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Country Table 30: East Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 31: East Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 32: East Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 33: East Asia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 34: Oceania Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Country Table 35: Oceania Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 36: Oceania Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 37: Oceania Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 38: Oceania Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 39: MEA Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Country Table 40: MEA Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 41: MEA Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 42: MEA Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 43: MEA Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 44: Emerging countries Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By region Table 45: China Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 46: China Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 47: China Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 48: China Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 49: India Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 50: India Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 51: India Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 52: India Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 53: Brazil Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 54: Brazil Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 55: Brazil Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 56: Brazil Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 57: U.S. Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 58: U.S. Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 59: U.S. Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 60: U.S. Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 61: Canada Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 62: Canada Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 63: Canada Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 64: Canada Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 65: Japan Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 66: Japan Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 67: Japan Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 68: Japan Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 69: South Korea Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 70: South Korea Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 71: South Korea Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 72: South Korea Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 73: Australia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 74: Australia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 75: Australia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 76: Australia Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel Table 77: New Zealand Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Therapy Type Table 78: New Zealand Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Route of Administration Table 79: New Zealand Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Patient Type Table 80: New Zealand Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022 - 2029, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Preterm Birth Prevention and Management Market Share, By Country (2021) Figure 02: Preterm Birth Prevention and Management Market Share, By Therapy Type (2021) Figure 03: Preterm Birth Prevention and Management Market Share, By Route of Administration (2021) Figure 04: Preterm Birth Prevention and Management Market Share, By Patient Type (2021) Figure 05: Preterm Birth Prevention and Management Market Share, By Distribution Channel (2021) Figure 06: GDP (US$ Trillion) and Healthcare Expenditure % (2017) Figure 07: Net National income, Income Growth and Employment (2014) Figure 08: Global Preterm Birth Prevention and Management Market Value Analysis (US$ Mn), 2014-2021 Figure 09: Global Preterm Birth Prevention and Management Market Value Analysis (US$ Mn), 2022-2029 Figure 10: Global Preterm Birth Prevention and Management Market Absolute $ Opportunity, 2014-2021 Figure 11: Global Preterm Birth Prevention and Management Market Absolute $ Opportunity, 2022-2029 Figure 12: Global Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029 Figure 13: Global Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029 Figure 14: Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Therapy Type Figure 15: Global Preterm Birth Prevention and Management Market Share Analysis (%) By Route of Administration, 2022 & 2029 Figure 16: Global Preterm Birth Prevention and Management Market Y-o-Y Growth (%) By Route of Administration, 2022-2029 Figure 17: Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Route of Administration Figure 18: Global Preterm Birth Prevention and Management Market Share Analysis (%) By Patient Type , 2022 & 2029 Figure 19: Global Preterm Birth Prevention and Management Market Y-o-Y Growth (%) By Patient Type , 2022-2029 Figure 20: Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Patient Type Figure 21: Global Preterm Birth Prevention and Management Market Share Analysis (%) By Distribution Channel , 2022 & 2029 Figure 22: Global Preterm Birth Prevention and Management Market Y-o-Y Growth (%) By Distribution Channel , 2022-2029 Figure 23: Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Distribution Channel Figure 24: Global Preterm Birth Prevention and Management Market Share Analysis (%) By Region, 2022 & 2029 Figure 25: Global Preterm Birth Prevention and Management Market Y-o-Y Growth (%) By Region, 2022-2029 Figure 26: Global Preterm Birth Prevention and Management Market Attractiveness Analysis, By Region Figure 27: North America Preterm Birth Prevention and Management Market Size (US$ Mn), 2014-2021 Figure 28: North America Preterm Birth Prevention and Management Market Size (US$) & Y-o-Y Growth (%), 2022-2029 Figure 29: North America Preterm Birth Prevention and Management Market Analysis by Country - 2022 & 2029 Figure 30: North America Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Country, 2022-2029 Figure 31: North America Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029 Figure 32: North America Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029 Figure 33: North America Preterm Birth Prevention and Management Market Attractiveness Analysis by Country, 2022-2029 Figure 34: North America Preterm Birth Prevention and Management Market Attractiveness Analysis by Therapy Type, 2022-2029 Figure 35: North America Preterm Birth Prevention and Management Market Attractiveness Analysis by Route of Administration, 2022-2029 Figure 36: North America Preterm Birth Prevention and Management Market Attractiveness Analysis by Patient Type, 2022-2029 Figure 37: North America Preterm Birth Prevention and Management Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 38: Latin America Preterm Birth Prevention and Management Market Size (US$ Mn), 2014-2021 Figure 39: Latin America Preterm Birth Prevention and Management Market Size (US$) & Y-o-Y Growth (%), 2022-2029 Figure 40: Latin America Preterm Birth Prevention and Management Market Analysis by Country - 2022 & 2029 Figure 41: Latin America Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Country, 2022-2029 Figure 42: Latin America Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029 Figure 43: Latin America Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029 Figure 44: Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis by Country, 2022-2029 Figure 45: Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis by Therapy Type, 2022-2029 Figure 46: Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis by Route of Administration, 2022-2029 Figure 47: Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis by Patient Type, 2022-2029 Figure 48: Latin America Preterm Birth Prevention and Management Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 49: Europe Preterm Birth Prevention and Management Market Size (US$ Mn), 2014-2021 Figure 50: Europe Preterm Birth Prevention and Management Market Size (US$) & Y-o-Y Growth (%), 2022-2029 Figure 51: Europe Preterm Birth Prevention and Management Market Analysis by Country - 2022 & 2029 Figure 52: Europe Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Country, 2022-2029 Figure 53: Europe Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029 Figure 54: Europe Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029 Figure 55: Europe Preterm Birth Prevention and Management Market Attractiveness Analysis by Country, 2022-2029 Figure 56: Europe Preterm Birth Prevention and Management Market Attractiveness Analysis by Therapy Type, 2022-2029 Figure 57: Europe Preterm Birth Prevention and Management Market Attractiveness Analysis by Route of Administration, 2022-2029 Figure 58: Europe Preterm Birth Prevention and Management Market Attractiveness Analysis by Patient Type, 2022-2029 Figure 59: Europe Preterm Birth Prevention and Management Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 60: South Asia Preterm Birth Prevention and Management Market Size (US$ Mn), 2014-2021 Figure 61: South Asia Preterm Birth Prevention and Management Market Size (US$) & Y-o-Y Growth (%), 2022-2029 Figure 62: South Asia Preterm Birth Prevention and Management Market Analysis by Country - 2022 & 2029 Figure 63: South Asia Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Country, 2022-2029 Figure 64: South Asia Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029 Figure 65: South Asia Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029 Figure 66: South Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Country, 2022-2029 Figure 67: South Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Therapy Type, 2022-2029 Figure 68: South Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Route of Administration, 2022-2029 Figure 69: South Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Patient Type, 2022-2029 Figure 70: South Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 71: East Asia Preterm Birth Prevention and Management Market Size (US$ Mn), 2014-2021 Figure 72: East Asia Preterm Birth Prevention and Management Market Size (US$) & Y-o-Y Growth (%), 2022-2029 Figure 73: East Asia Preterm Birth Prevention and Management Market Analysis by Country - 2022 & 2029 Figure 74: East Asia Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Country, 2022-2029 Figure 75: East Asia Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029 Figure 76: East Asia Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029 Figure 77: East Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Country, 2022-2029 Figure 78: East Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Therapy Type, 2022-2029 Figure 79: East Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Route of Administration, 2022-2029 Figure 80: East Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Patient Type, 2022-2029 Figure 81: East Asia Preterm Birth Prevention and Management Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 82: Oceania Preterm Birth Prevention and Management Market Size (US$ Mn), 2014-2021 Figure 83: Oceania Preterm Birth Prevention and Management Market Size (US$) & Y-o-Y Growth (%), 2022-2029 Figure 84: Oceania Preterm Birth Prevention and Management Market Analysis by Country - 2022 & 2029 Figure 85: Oceania Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Country, 2022-2029 Figure 86: Oceania Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029 Figure 87: Oceania Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029 Figure 88: Oceania Preterm Birth Prevention and Management Market Attractiveness Analysis by Country, 2022-2029 Figure 89: Oceania Preterm Birth Prevention and Management Market Attractiveness Analysis by Therapy Type, 2022-2029 Figure 90: Oceania Preterm Birth Prevention and Management Market Attractiveness Analysis by Route of Administration, 2022-2029 Figure 91: Oceania Preterm Birth Prevention and Management Market Attractiveness Analysis by Patient Type, 2022-2029 Figure 92: Oceania Preterm Birth Prevention and Management Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 93: MEA Preterm Birth Prevention and Management Market Size (US$ Mn), 2014-2021 Figure 94: MEA Preterm Birth Prevention and Management Market Size (US$) & Y-o-Y Growth (%), 2022-2029 Figure 95: MEA Preterm Birth Prevention and Management Market Analysis by Country - 2022 & 2029 Figure 96: MEA Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Country, 2022-2029 Figure 97: MEA Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029 Figure 98: MEA Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029 Figure 99: MEA Preterm Birth Prevention and Management Market Attractiveness Analysis by Country, 2022-2029 Figure 100: MEA Preterm Birth Prevention and Management Market Attractiveness Analysis by Therapy Type, 2022-2029 Figure 101: MEA Preterm Birth Prevention and Management Market Attractiveness Analysis by Route of Administration, 2022-2029 Figure 102: MEA Preterm Birth Prevention and Management Market Attractiveness Analysis by Patient Type, 2022-2029 Figure 103: MEA Preterm Birth Prevention and Management Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 104: Emerging countries Preterm Birth Prevention and Management Market Size (US$ Mn) Analysis, 2021 Figure 105: Emerging countries Preterm Birth Prevention and Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2014 - 2029 Figure 106: U.S. Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029 Figure 107: U.S. Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029 Figure 108: Canada Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029 Figure 109: Canada Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029 Figure 110: Japan Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029 Figure 111: Japan Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029 Figure 112: South Korea Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029 Figure 113: South Korea Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029 Figure 114: Australia Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029 Figure 115: Australia Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029 Figure 116: New Zealand Preterm Birth Prevention and Management Market Analysis by Therapy Type -2022 & 2029 Figure 117: New Zealand Preterm Birth Prevention and Management Market Y-o-Y Growth Projections by Therapy Type, 2022-2029 Figure 118: Global Preterm Birth Prevention and Management Market Share, By Value of Prominent Key Players, 2021
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
